THE BRIGHAM & WOMENS HOSPITAL INC has a total of 11 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), Australia and Jordan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SHANGHAI FUDAN ZHANGJIANG BIO, VANWORLD PHARMACEUTICAL RUGAO CO LTD and ZEALAND PHARMA A.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Australia | 3 | |
#3 | Jordan | 1 | |
#4 | United States | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Environmental technology | |
#6 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Zarei Mahsa | 2 |
#2 | Serhan Charles N | 2 |
#3 | Dalli Jesmond | 2 |
#4 | Blumberg Richard S | 2 |
#5 | Ralph Leon Biemans | 1 |
#6 | Bradner James Elliot | 1 |
#7 | Shen Jie | 1 |
#8 | Clement Gregory T | 1 |
#9 | Huang Yu-Hwa | 1 |
#10 | Kelleher Iii Raymond J | 1 |
Publication | Filing date | Title |
---|---|---|
EP3762027A1 | Therapeutic fcrn-based bispecific monoclonal antibodies | |
US2020197392A1 | Compositions and methods for treating tuberous sclerosis complex | |
EP3777534A1 | Compositions and methods for ex vivo expansion of human hematopoietic stem/progenitor cells | |
JO3420B1 | Pharmaceutical composition and vaccine against staphylococcal infections |